PW Medtech Group Ltd

FRA:PWE (China)  
€ 0.13 (-0.79%) Jun 17
10.00
P/B:
0.38
Market Cap:
€ 199.98M ($ 214.31M)
Enterprise V:
€ -9.24M ($ -9.90M)
Volume:
-
Avg Vol (2M):
2.02K
Trade In:
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for PW Medtech Group Ltd ( ) from 2013 to Jun 18 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. PW Medtech Group stock (FRA:PWE) PE ratio as of Jun 18 2024 is 10. More Details

PW Medtech Group Ltd (FRA:PWE) PE Ratio (TTM) Chart

To

PW Medtech Group Ltd (FRA:PWE) PE Ratio (TTM) Historical Data

Total 1262
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
PW Medtech Group PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-18 9.6 2024-04-15 7.4
2024-06-17 9.6 2024-04-12 7.5
2024-06-14 9.7 2024-04-11 7.5
2024-06-13 9.5 2024-04-10 8.5
2024-06-12 9.5 2024-04-09 7.5
2024-06-11 9.5 2024-04-08 7.3
2024-06-10 9.5 2024-04-05 7.1
2024-06-07 9.7 2024-04-04 8.1
2024-06-06 9.8 2024-04-03 7.3
2024-06-05 11.1 2024-04-02 7.5
2024-06-04 8.7 2024-03-28 7.7
2024-06-03 7.9 2024-03-27 7.3
2024-05-31 7.7 2024-03-26 7.4
2024-05-30 7.7 2024-03-25 8.8
2024-05-29 7.6 2024-03-22 7.3
2024-05-28 7.6 2024-03-21 7.3
2024-05-27 7.6 2024-03-20 8.2
2024-05-24 7.8 2024-03-19 7.2
2024-05-23 7.8 2024-03-18 7.3
2024-05-22 7.8 2024-03-15 7.2
2024-05-21 7.8 2024-03-14 7.0
2024-05-20 7.8 2024-03-13 6.1
2024-05-17 9.2 2024-03-12 6.1
2024-05-16 7.9 2024-03-11 7.7
2024-05-15 8.2 2024-03-08 6.2
2024-05-14 8.2 2024-03-07 5.9
2024-05-13 8.1 2024-03-06 6.0
2024-05-10 8.2 2024-03-05 5.7
2024-05-09 8.1 2024-03-04 5.6
2024-05-08 7.8 2024-03-01 5.5
2024-05-07 8.5 2024-02-29 5.7
2024-05-06 7.6 2024-02-28 5.5
2024-05-03 7.5 2024-02-27 5.7
2024-05-02 7.4 2024-02-26 5.7
2024-04-30 7.4 2024-02-23 5.7
2024-04-29 7.5 2024-02-22 7.4
2024-04-26 7.5 2024-02-21 5.7
2024-04-25 7.5 2024-02-20 5.7
2024-04-24 7.5 2024-02-19 5.6
2024-04-23 7.4 2024-02-16 6.0
2024-04-22 7.5 2024-02-15 5.7
2024-04-19 7.5 2024-02-14 5.7
2024-04-18 7.5 2024-02-13 5.7
2024-04-17 7.5 2024-02-12 5.7
2024-04-16 7.4 2024-02-09 5.7

PW Medtech Group Ltd (FRA:PWE) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
PW Medtech Group Ltd is a medical device company with a focus on fast-growing and high-margin segments of China's medical device industry. The company is engaged in the research and development, manufacturing, and sale of the advanced infusion set, intravenous cannula products, and insulin needles. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, and insulin needles and pens. The company operates through three business segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business. It generates maximum revenue from Blood Purification Business. Geographically, it operates in China, North America, India and Others.